How to Report a Shortage or Supply Issue
How to Report a Shortage or Supply Issue
Nonprescription Drugs Advisory Committee Roster
This page contains the Nonprescription Drugs Advisory Committee Roster, which lists the current members and the current number of vacancies…
Food and Drug Administration Overdose Prevention Framework
Working across the Agency, FDA’s Overdose Prevention priorities closely align with HHS and bring together our ongoing and proposed activities…
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
Q&A with FDA Podcast
“Q&A with FDA” is a monthly podcast series that provides engaging conversation and discussion about the latest regulatory topics. In…
FDA Drug Safety Podcasts
FDA Drug Safety Podcasts are produced by FDA’s Center for Drug Evaluation and Research (CDER)
Hematological ABP: Interest of New Generation Sequencing Methods (NGS) to Study Suspicious Fluctuations in Erythropoiesis
Fluctuations in haematological parameters in the ABP are not necessarily due to doping. In this case, the 48 sample, despite…
Limited number of voluntary recalls initiated after FDA testing of acne products for benzene; findings show a small number of products with elevated levels of benzene contamination
Voluntary recalls of acne products after FDA testing finds small number of proudcts with elevated levels of benzene
FDA Roundup: March 11, 2025
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Office of Generic Drugs | Offices and Divisions
Generic Drugs Offices and Divisions